Randomized clinical trial: Long-term Staphylococcus aureus decolonization in patients on home parenteral nutrition
Radboudumc 18: Healthcare improvement science IQ Healthcare
Adult
Home parenteral nutrition
Parenteral Nutrition
Radboudumc 4: lnfectious Diseases and Global Health Internal Medicine
Staphylococcus aureus
Radboud University Medical Center
Radboudumc 18: Healthcare improvement science Primary and Community Care
S. aureus carriage
Radboudumc 18: Healthcare improvement science 18-Primary and Community Care
Staphylococcal Infections
Radboudumc 4: lnfectious Diseases and Global Health Medical Microbiology
3. Good health
Radboudumc 4: lnfectious Diseases and Global Health Gastroenterology
Anti-Bacterial Agents
Decolonization
Central venous access device
Risk Factors
Radboudumc 18: Healthcare improvement science Health Evidence
Humans
Home
Parenteral Nutrition, Home
Central venous catheter
DOI:
10.1016/j.clnu.2023.03.010
Publication Date:
2023-03-17T16:11:07Z
AUTHORS (14)
ABSTRACT
Staphylococcus aureus decolonization has proven successful in prevention of S. aureus infections and is a key strategy to maintain venous access and avoid hospitalization in patients receiving home parenteral nutrition (HPN). We aimed to determine the most effective and safe long-term S. aureus decolonization regimen.A randomized, open-label, multicenter clinical trial was conducted. Adult intestinal failure patients with HPN support and carrying S. aureus were randomly assigned to a 'continuous suppression' (CS) strategy, a repeated chronic topical antibiotic treatment or a 'search and destroy' (SD) strategy, a short and systemic antibiotic treatment. Primary outcome was the proportion of patients in whom S. aureus was totally eradicated during a 1-year period. Secondary outcomes included risk factors for decolonization failure and S. aureus infections, antimicrobial resistance, adverse events, patient compliance and cost-effectivity.63 participants were included (CS 31; SD 32). The mean 1-year S. aureus decolonization rate was 61% (95% CI 44, 75) for the CS group and 39% (95% CI 25, 56) for the SD group with an OR of 2.38 (95% CI 0.92, 6.11, P = 0.07). More adverse effects occurred in the SD group (P = 0.01). Predictors for eradication failure were a S. aureus positive caregiver and presence of a (gastro)enterostomy.We did not demonstrate an increased efficacy of a short and systemic S. aureus decolonization strategy over a continuous topical suppression treatment. The latter may be the best option for HPN patients as it achieved a higher long-term decolonization rate and was well-tolerated (NCT03173053).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (45)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....